Novartis

Biogen, watch out: Novartis' Tysabri biosim application could portend multiple sclerosis showdown in Europe and US
Fierce Pharma
Wed, 07/27/22 - 10:58 am
Novartis
Biogen
multiple sclerosis
MS
Tysabri
biosimilars
Novartis fails to win appeal in whistleblower case involving cancer drug study
Endpoints
Tue, 07/26/22 - 05:29 pm
Novartis
legal
whistleblowers
Novartis asks FDA to approve biosimilar for Biogen’s top-selling MS drug
BioPharma Dive
Mon, 07/25/22 - 09:54 pm
Novartis
FDA
Biogen
biosimilars
Tysabri
MS
multiple sclerosis
What This FDA Delay Means for Novartis
Motley Fool
Thu, 07/21/22 - 10:36 am
Novartis
FDA
cancer
tislelizumab
Moving Away from Asthma and COPD, Novartis Hones in on 20 Approvals by 2026
BioSpace
Thu, 07/21/22 - 10:24 am
Novartis
asthma
COPD
Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz
Benzinga
Tue, 07/19/22 - 09:56 pm
Novartis
earnings
Novartis looking for new homes for midphase asthma, eye disease and NASH assets after pipeline review
Fierce Biotech
Tue, 07/19/22 - 10:36 am
Novartis
asthma
NASH
Retinitis pigmentosa
Novartis turns to algorithms developer Anumana to apply AI to cardio conditions
MedCity News
Sun, 07/17/22 - 10:41 pm
Novartis
Anumana
artificial intelligence
diagnostics
cardiovascular disease
Ex-Novartis sales rep claims discrimination, retaliation led to her firing after she reported misconduct
Fierce Pharma
Fri, 07/15/22 - 12:21 pm
Novartis
retaliation claims
discrimination
drug reps
FDA Indefinitely Delays BeiGene/Novartis anti-PD-1 Esophageal Cancer Drug
BioSpace
Thu, 07/14/22 - 10:51 am
Novartis
BeiGene
FDA
tislelizumab
esophageal cancer
Novartis suspends platform trial, advancement shot of four blood cancer assets drop
Clinical Trials Arena
Wed, 07/13/22 - 10:07 am
Novartis
clinical trials
blood cancer
tuberculosis
uterine leiomyoma
AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts
Fierce Pharma
Wed, 07/13/22 - 10:03 am
China
drug pricing
price cuts
AstraZeneca
Pfizer
Novartis
generics
6 Medtech Acquisitions That Went Horribly Wrong
Medical Devices and Diagnostics Industry
Thu, 07/7/22 - 08:10 pm
devices
Medtech
M&A
Medtronic
HeartWare
Second Sight Medical
Pixium Vision
Illumina
PacBio
Novartis
Alcon
Transcend
Organovo
Tarveda Therapeutics
Boston Scientific
Guidant
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
Wed, 07/6/22 - 11:05 am
FDA
drug approvals
Amicus
Bluebird Bio
Bristol Myers Squibb
Eli Lilly
Marinus Pharma
Amylyx
Novartis
Novartis offers $17.7m support in the fight for health equity
Biopharma Reporter
Tue, 07/5/22 - 11:10 am
Novartis
physicians
philanthropy
racial disparity
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
Fierce Pharma
Fri, 07/1/22 - 09:49 am
Novartis
spinoffs
generics
M&A
Sandoz
private equity
Novartis, BeiGene lay out frontline PhIII data for PD-1 drug as second-line PDUFA date looms
Endpoints
Thu, 06/30/22 - 12:11 pm
Novartis
BeiGene
FDA
tislelizumab
gastrointestinal cancer
Novartis Reveals Restructure will Cost up to 8,000 Jobs
BioSpace
Tue, 06/28/22 - 06:07 pm
Novartis
restructuring
layoffs
Novartis: FDA OKs Tafinlar + Mekinist For Solid Tumors With BRAF V600E Mutation
NASDAQ
Thu, 06/23/22 - 10:57 am
Novartis
FDA
Tafinlar+Mekinist
solid tumors
BRAF V600
Novartis pledges $250M in R&D funding for neglected tropical diseases, malaria
Endpoints
Thu, 06/23/22 - 10:37 am
Novartis
R&D
tropical diseases
malaria
neglected tropical diseases

Pages